Please login to the form below

Not currently logged in
Email:
Password:

Red Door Unlimited appoints head of social

Antia Buhigas joins the agency’s leadership team

Red Door Unlimited Antia BuhigasRichmond, UK-based Red Door Unlimited has appointed Antia Buhigas as its head of social, and to help deliver a new consumer health proposition.

In the role, Buhigas will be responsible for advising on social strategy across the agency's ethical PR portfolio, leading a team on behavioural change programmes.

She joins the health and wellbeing communications agency with over 15 years of experience in engagement strategising, and specialises in building social context in communications programmes.

Buhigas' experience includes working at Pegasus, the Brighton-based integrated health communications agency, and also serving clients such as Jack Morton, Merlin Entertainments and PhotoBox.

Catherine Devaney, Red Door's managing director, said: “Passion for people and communications might sound cliché but that's Antia in a nutshell – empathic, fiery and full of intent.

“We have built a team capable of both devising and delivering communications programmes which genuinely reflect what is influencing today's behaviours. Antia absolutely embodies our ambition and we are so please she has joined us.”

14th June 2016

From: Marketing

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
11 London

11 London is a strategic and creative agency working in the fields of health and humanity – complex areas, but...

Latest intelligence

4 ways to recruit Alzheimer’s disease patients for your clinical trial
What key things do you need to remember to reach patients living with Alzheimer’s disease?...
competitive intelligence
Integrating competitive intelligence into business development, licensing and M&A strategy
The advantages of partnering with a competitive intelligence or knowledge management team...
reaching HCPs during pandemic
Reaching patients and HCPs during the pandemic
COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...

Infographics